Using clinical trial data to assess the impact of empagliflozin on non-cardiovascular hospitalizations in patients with heart failure
October 1, 2024
| Heart Failure
| João Pedro Ferreira
Dr. Ferreira's research examines whether empagliflozin use could reduce lower respiratory tract infections and hospitalization in patients with heart failure.
View all Case Studies